Maurice Buchbinder

Endologix LLC engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA.

MiCardia Corp. designs, develops, and commercializes implantable medical devices. The firm offers implantable devices for the treatment of heart diseases, such as mitral valve regurgitation and congestive heart failure. It also provides enCor, an annuloplasty device that corrects residual mitral regurgitation on a beating heart. The company was founded in November 2004 by Michael R. Henson, Shawn Moaddeb and Samuel M. Shaolian and is headquartered in Irvine, CA.

Bioabsorbable Therapeutics, Inc. developed absorbable stent to treat vascular disease through the use of proprietary polymers. The company was founded in 2004 and was headquartered in Menlo Park, CA.

Finistere Ventures LLC (Finistere Ventures) is a venture capital firm founded by Spencer Maughan and Arama Kukutai in 2005. The firm is headquartered in Newport Beach, California.

American College of Cardiology Foundation provides cardiovascular education services. Its services include cardiac surgery, chronic angine, diabetes, geriatric cardiology and heart failure and cardiomyopathies. The company was founded by Franz Groedel, Robert P. Glover and Bruno Kisc in 1949 and is headquartered in Washington, DC.

California Medical Association is an organization that represents over 50,000 physicians in California across various modes of practice and specialties. The non-profit company is based in Sacramento, CA and has subsidiaries in the United States. The company is dedicated to improving the health of all patients in the state. The CEO of the company is Dustin Corcoran.

CardioDex Ltd. develops medical devices for vascular diseases. The company develops, manufactures and markets a disposable solution for the closure of arterial access sites following endovascular catheterization procedures. CardioDex was founded in 1999 by Shimon Eckhouse and Menachem Zucker and is headquartered in Cesarea, Israel.

EndoCross Ltd. develops medical devices for cardiovascular arena. Its products ENABLER-P catheter system, is designed for use in the peripheral vasculature including both the above the knee and below the knee vessels, and ENABLER-C catheter system, for use in the coronary environments. The company was founded by Eran Levit and Eran Hirszowicz in 2006 and is headquartered in Yokneam Illit, Israel.